Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Baxter raises outlook following “strong” Q2

Baxter raises outlook following “strong” Q2

18th July 2008

Baxter International has raised its yearly financial outlook after released its financial results for the second quarter of 2008.

The company reported earnings per diluted share of $0.85 (0.42 pounds) and a net income of $544 million for the second quarter.

Net income has increased from the second quarter of 2007 by 26 per cent to $431 million.

When compared to 2007, total net income increased 14 per cent.

Robert L Parkinson Junior, chairman and chief executive officer of Baxter, said: “Our positive financial performance in the first half of 2008 continues to reflect the strength of our diversified business model, and positions us well in this uncertain global economy.”

Sales reached $3.2 billion worldwide during the second quarter showing an increase of 13 per cent and sales for the first six months of 2008 was $973 million.

The pharmaceutical company creates products to treat people with cancer, kidney disease, hemophilia and immune disorders.

It has been working in healthcare for over 75 years.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.